Vivos (RDGL) Return on Capital Employed Growth (3y) (2014 - 2025)
Vivos (RDGL) Return on Capital Employed Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 362.00 |
| 10 | Vivos | - | - | -3,105.00 | -2,230.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,230.00 |
| Sep 30, 2025 | 3,065.00 |
| Jun 30, 2025 | 9,277.00 |
| Mar 31, 2025 | 10,855.00 |
| Dec 31, 2024 | -797.00 |
| Sep 30, 2024 | -2,811.00 |
| Jun 30, 2024 | -5,163.00 |
| Mar 31, 2024 | -14,401.00 |
| Dec 31, 2023 | -37,285.00 |
| Sep 30, 2023 | -25,638.00 |
| Dec 31, 2022 | -23,368.00 |
| Sep 30, 2022 | -35,873.00 |
| Jun 30, 2022 | -38,032.00 |
| Mar 31, 2022 | -44,523.00 |
| Dec 31, 2021 | -41,320.00 |
| Sep 30, 2021 | -17,391.00 |
| Jun 30, 2021 | -16,324.00 |
| Mar 31, 2021 | -12,560.00 |
| Dec 31, 2020 | 10,343.00 |
| Sep 30, 2020 | 3,980.00 |